Literature DB >> 27631701

The Potency of Nef-Mediated SERINC5 Antagonism Correlates with the Prevalence of Primate Lentiviruses in the Wild.

Anke Heigele1, Dorota Kmiec1, Kerstin Regensburger1, Simon Langer1, Lukas Peiffer1, Christina M Stürzel1, Daniel Sauter1, Martine Peeters2, Massimo Pizzato3, Gerald H Learn4, Beatrice H Hahn5, Frank Kirchhoff6.   

Abstract

The cellular factor serine incorporator 5 (SERINC5) impairs HIV-1 infectivity but is antagonized by the viral Nef protein. We analyzed the anti-SERINC5 activity of Nef proteins across primate lentiviruses and examined whether SERINC5 represents a barrier to cross-species transmissions and/or within-species viral spread. HIV-1, HIV-2, and SIV Nefs counteract human, ape, monkey, and murine SERINC5 orthologs with similar potency. However, HIV-1 Nefs are more active against SERINC5 than HIV-2 Nefs, and chimpanzee SIV (SIVcpz) Nefs are more potent than those of their monkey precursors. Additionally, Nefs of HIV and most SIVs rely on the dileucine motif in the C-terminal loop for anti-SERINC5 activity, while the Nef from colobus SIV (SIVcol) evolved different inhibitory mechanisms. We also found a significant correlation between anti-SERINC5 potency and the SIV prevalence in the respective ape and monkey species. Thus, Nef-mediated SERINC5 antagonism may determine the ability of primate lentiviruses to spread within natural hosts.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27631701      PMCID: PMC5098270          DOI: 10.1016/j.chom.2016.08.004

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  49 in total

1.  Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A.

Authors:  C Aiken
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Down-modulation of CD8αβ is a fundamental activity of primate lentiviral Nef proteins.

Authors:  Anke Heigele; Michael Schindler; Clement W Gnanadurai; Jolie A Leonard; Kathleen L Collins; Frank Kirchhoff
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

Review 3.  Evolutionary genomics and HIV restriction factors.

Authors:  Nitisha Pyndiah; Amalio Telenti; Antonio Rausell
Journal:  Curr Opin HIV AIDS       Date:  2015-03       Impact factor: 4.283

Review 4.  HIV-1 Nef: a master manipulator of the membrane trafficking machinery mediating immune evasion.

Authors:  Emily N Pawlak; Jimmy D Dikeakos
Journal:  Biochim Biophys Acta       Date:  2015-01-10

5.  Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection.

Authors:  F Kirchhoff; T C Greenough; D B Brettler; J L Sullivan; R C Desrosiers
Journal:  N Engl J Med       Date:  1995-01-26       Impact factor: 91.245

6.  Modulation of different human immunodeficiency virus type 1 Nef functions during progression to AIDS.

Authors:  S Carl; T C Greenough; M Krumbiegel; M Greenberg; J Skowronski; J L Sullivan; F Kirchhoff
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

7.  Origin of the HIV-1 group O epidemic in western lowland gorillas.

Authors:  Mirela D'arc; Ahidjo Ayouba; Amandine Esteban; Gerald H Learn; Vanina Boué; Florian Liegeois; Lucie Etienne; Nikki Tagg; Fabian H Leendertz; Christophe Boesch; Nadège F Madinda; Martha M Robbins; Maryke Gray; Amandine Cournil; Marcel Ooms; Michael Letko; Viviana A Simon; Paul M Sharp; Beatrice H Hahn; Eric Delaporte; Eitel Mpoudi Ngole; Martine Peeters
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-02       Impact factor: 11.205

8.  Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains.

Authors:  Daniel Sauter; Michael Schindler; Anke Specht; Wilmina N Landford; Jan Münch; Kyeong-Ae Kim; Jörg Votteler; Ulrich Schubert; Frederic Bibollet-Ruche; Brandon F Keele; Jun Takehisa; Yudelca Ogando; Christina Ochsenbauer; John C Kappes; Ahidjo Ayouba; Martine Peeters; Gerald H Learn; George Shaw; Paul M Sharp; Paul Bieniasz; Beatrice H Hahn; Theodora Hatziioannou; Frank Kirchhoff
Journal:  Cell Host Microbe       Date:  2009-11-19       Impact factor: 21.023

9.  Conservation of Nef function across highly diverse lineages of SIVsmm.

Authors:  Jan Schmökel; Hui Li; Elizabeth Bailes; Michael Schindler; Guido Silvestri; Beatrice H Hahn; Cristian Apetrei; Frank Kirchhoff
Journal:  Retrovirology       Date:  2009-04-09       Impact factor: 4.602

10.  The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages.

Authors:  M D Miller; M T Warmerdam; I Gaston; W C Greene; M B Feinberg
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

View more
  50 in total

1.  CD4 Expression and Env Conformation Are Critical for HIV-1 Restriction by SERINC5.

Authors:  Xihe Zhang; Jing Shi; Xusheng Qiu; Qingqing Chai; Dylan A Frabutt; Richard C Schwartz; Yong-Hui Zheng
Journal:  J Virol       Date:  2019-06-28       Impact factor: 5.103

Review 2.  Exposing HIV's weaknesses.

Authors:  Philip R Tedbury; Stefan G Sarafianos
Journal:  J Biol Chem       Date:  2017-04-07       Impact factor: 5.157

3.  SERINC5 protein inhibits HIV-1 fusion pore formation by promoting functional inactivation of envelope glycoproteins.

Authors:  Chetan Sood; Mariana Marin; Ajit Chande; Massimo Pizzato; Gregory B Melikyan
Journal:  J Biol Chem       Date:  2017-02-08       Impact factor: 5.157

4.  Smc5/6 Antagonism by HBx Is an Evolutionarily Conserved Function of Hepatitis B Virus Infection in Mammals.

Authors:  Fabien Abdul; Fabien Filleton; Laetitia Gerossier; Alexia Paturel; Janet Hall; Michel Strubin; Lucie Etienne
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

5.  Maintenance of AP-2-Dependent Functional Activities of Nef Restricts Pathways of Immune Escape from CD8 T Lymphocyte Responses.

Authors:  Blake Schouest; Andrea M Weiler; Sanath Kumar Janaka; Tereance A Myers; Arpita Das; Sarah C Wilder; Jessica Furlott; Melody Baddoo; Erik K Flemington; Eva G Rakasz; David T Evans; Thomas C Friedrich; Nicholas J Maness
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

6.  CD4- and Time-Dependent Susceptibility of HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity.

Authors:  Wen Shi Lee; Jérémie Prévost; Jonathan Richard; Reneé M van der Sluis; Sharon R Lewin; Marzena Pazgier; Andrés Finzi; Matthew S Parsons; Stephen J Kent
Journal:  J Virol       Date:  2019-05-01       Impact factor: 5.103

7.  Multifunctional Roles of the N-Terminal Region of HIV-1SF2Nef Are Mediated by Three Independent Protein Interaction Sites.

Authors:  Swetha Ananth; Katharina Morath; Birthe Trautz; Nadine Tibroni; Iart Luca Shytaj; Benedikt Obermaier; Bettina Stolp; Marina Lusic; Oliver T Fackler
Journal:  J Virol       Date:  2019-12-12       Impact factor: 5.103

8.  The host-cell restriction factor SERINC5 restricts HIV-1 infectivity without altering the lipid composition and organization of viral particles.

Authors:  Birthe Trautz; Hannah Wiedemann; Christian Lüchtenborg; Virginia Pierini; Jan Kranich; Bärbel Glass; Hans-Georg Kräusslich; Thomas Brocker; Massimo Pizzato; Alessia Ruggieri; Britta Brügger; Oliver T Fackler
Journal:  J Biol Chem       Date:  2017-06-28       Impact factor: 5.157

9.  Primary HIV-1 Strains Use Nef To Downmodulate HLA-E Surface Expression.

Authors:  Thomas van Stigt Thans; Janet I Akko; Annika Niehrs; Wilfredo F Garcia-Beltran; Laura Richert; Christina M Stürzel; Christopher T Ford; Hui Li; Christina Ochsenbauer; John C Kappes; Beatrice H Hahn; Frank Kirchhoff; Glòria Martrus; Daniel Sauter; Marcus Altfeld; Angelique Hölzemer
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

10.  Murine Leukemia Virus Glycosylated Gag Reduces Murine SERINC5 Protein Expression at Steady-State Levels via the Endosome/Lysosome Pathway to Counteract SERINC5 Antiretroviral Activity.

Authors:  Sunan Li; Iqbal Ahmad; Jing Shi; Bin Wang; Changqing Yu; Lixin Zhang; Yong-Hui Zheng
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.